These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-003458-81 A randomized phase III trial on first line metastatic colorectal carcinoma GOLFIG gemcitabine FOLFOX-4 GM-CSF and interleukin 2 chemo-immunotherapy vs standard FOLFOX-4 chemotherapy bad-data
Completed, but no date 2005-005998-29 FIVE- VERSUS SEVEN-DAY SUBCUTANEOUS ADMINISTRATION OF CLADRIBINE IN HAIRY CELL LEUKEMIA bad-data
Completed, but no date 2006-000908-17 Medical therapy of keratoconus with Riboflavin/Ultraviolet-A collagen Cross-Linking and investigation of the corneal stromal and Keratocytes modifications apoptosis and stromal repopulation with con... bad-data
Completed, but no date Terminated 2006-001547-59 Clinical study on the efficacy and safety of extracorporeal blood oxygenation and ozonation in ischemic cardiovascular patients bad-data
Completed, but no date 2006-001889-16 Use of clembuterol in patients affected by valvular hearth disease and dilated cardiomyopathy bad-data
Completed, but no date Terminated 2006-004320-36 Intravitreal Bevacizumab (Avastin) for neovascular age-related macular degeneration bad-data
Completed, but no date Terminated 2006-005391-40 Study on the effect of intra-articular infiltrations of aulogous platelet gel as inhibitor of erosion in rheumatoid arthritis patients bad-data
Completed, but no date 2007-001996-13 Intravenous glycoprotein IIbIIIa inhibitor (Tirofiban) combined with low dose of intra-arterial Urokinase for the endovascolar treatment of patients with acute major ischemic stroke bad-data
Completed, but no date Terminated 2007-003278-24 A PHASE II STUDY OF THE EFFECTIVENESS AND TOLERABILITY OF PEGYLATED LIPOSOMAL DOXORUBICIN IN ASSOCIATION WITH DAILY ORAL CYCLOPHOSPHAMIDE IN METASTATIC BREAST CANCER PATIENTS bad-data
Ongoing 2007-005674-31 NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGICAL DEBULKING AND INTRAPERITONEAL CHEMOHYPERTHERMIA FOR STAGE III OVARIAN CANCER. A PROSPECTIVE PHASE II STUDY not-yet-due
Completed, but no date 2007-006515-23 Randomized clinical trial for the local therapy of carpal tunnel syndrome: cortisone vs progesterone bad-data
Completed, but no date 2007-006525-26 efficacy of TachoSil on air leakage in chest surgery bad-data
Completed, but no date 2008-000217-30 Treatment with Oxaliplatin and Irinotecan in colorectal metastatic tumors with high expression of thymidilate synthase (TS). bad-data
Completed, but no date 2008-001185-91 Central randomized, double-blind, crossover, multicenter clinical trial of Betametasone and placebo in children with ataxia teleangectasia bad-data
Completed, but no date 2008-005171-95 A SECOND-LINE, SINGLE ARM, PHASE II CLINICAL STUDY WITH TREMELIMUMAB, A FULLY HUMANIZED ANTI-CTLA-4 MONOCLONAL ANTIBODY, AS MONOTHERAPY IN PATIENTS WITH UNRESECTABLE MALIGNANT MESOTHELIOMA bad-data
Completed, but no date Terminated 2008-005583-14 NEW CONSERVATIVE THERAPIES IN RETINOBLASTOMA: DIRECT INTRAARTERIAL (OPHTALMIC ARTERY) CHEMOTHERAPY WITH MELPHALAN FOR INTRAOCULAR RETINOBLASTOMA bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005667-34 Randomised Trial of Genetic Testing and Targeted Zoledronic acid Therapy to Prevent SQSTM1 Mediated Paget’s Disease Studio clinico randomizzato di analisi genetica e terapia mirata con acido zoledr... 2022-05-31 bad-data
Completed, but no date 2008-006051-40 A PHASE II STUDY: UNOPERABLE NON NON SQUAMOUS NON SMALL CELL LUNG CANCER METRONOMIC BIOCHEMOTHERAPY WITH WEEKLY CISPLATIN, DAILY ORAL ETOPOSIDE AND BEVACIZUMAB (mPEBev regimen) bad-data
Completed, but no date Terminated 2009-012707-26 THERAPEUTIC EFFECTIIVENESS OF N-ACETYL-CYSTEINE AND ASCORBIC ACID IN PATIENTS WITH ALKAPTONURIA-OCHRONOSIS bad-data
Completed, but no date 2009-017379-90 Characterization of the secondary failure to TNF-blockers monoclonal antibodies. Receptor as a rescue therapy bad-data
Completed, but no date Terminated 2010-019756-42 Sequential first line chemotherapy ECF (epirubicin + cisplatin + 5-fluoruracil) followed by DCF (docetaxel + cisplatin + 5-fluoruracil) in advanced/metastatic gastric cancer HER-2 negative: a phase II... bad-data
Completed, but no date, and reported results 2011-004518-40 Serological response to antipneumococcal vaccination and consequent impact on Streptococcus pneumoniae nasal carriage in HIV positive adults: a prospective study using 13-valent conjugate vaccine R... bad-data
Completed, but no date, and reported results 2012-002762-12 A SECOND-LINE, SINGLE ARM, PHASE II CLINICAL STUDY WITH TREMELIMUMAB, A FULLY HUMANIZED ANTI-CTLA-4 MONOCLONAL ANTIBODY, AS MONOTHERAPY IN PATIENTS WITH UNRESECTABLE MALIGNANT MESOTHELIOMA Studio c... bad-data
Ongoing 2012-002825-31 NEW CONSERVATIVE THERAPIES IN RETINOBLASTOMA: INTRAVITREAL AND SUBCONJUNCITIVAL INJECTION OF CHEMOTHERAPY in the intraoculars RTBs Nuove terapie conservative nel retinoblastoma (RTB): iniezione in... not-yet-due
Completed, but no date, and reported results 2015-005303-91 Clinical Trial of pharmacokinetics of calcifediol (25OHD3) in women with postmenopausal osteoporosis Studio sui lievelli circolanti di 25OHD3 in donne affette da osteoporosi postmenopausale trattat... bad-data
Ongoing 2016-004136-38 PROSPECTIC, RANDOMIZED, NATIONAL MULTICENTRIC STUDY, FINALIZED TO ASSESS THE STABILITY OF TSH LEVELS IN THYROIDECTOMISED PATIENTS IN THERAPY WITH TWO FORMULATIONS OF LEVOTYROXIN (TABLETS AND SOFT-GEL)... not-yet-due
Ongoing 2018-000386-36 A Pilot study on the efficacy of Daratumumab in Multiple Myeloma (MM) patients in >VGPR/MRD-positive by next generation flow (NGF) STUDIO PILOTA SULL’EFFICACIA DI DARATUMUMAB IN PAZIENTI AFFETTI DA... not-yet-due
Ongoing 2018-003313-17 Efficacy of vitamin D supplementation in patients with depressive disorder or bipolar disorder: randomized controlled clinical trial Efficacia della supplementazione con vitamina d in pazienti con ... not-yet-due
Not reported 2018-004885-32 THE EFFECTS OF SWITCHING FROM DOLUTEGRAVIR/LAMIVUDINE/ABACAVIR (D/L/A) TO BICTEGRAVIR/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (B/F/TAF) IN PATIENTS WITH SUPPRESSED VIRAL LOAD ON NEUROPSYCHIATRIC SIDE EFFE... 2023-04-30 due-trials
Not reported 2021-005394-66 Effects of Dapagliflozin on cardiac deformation and clinical outcomes in heart failure with reduced and mildly reduced ejection fraction Effetti del Dapagliflozin sulla deformazione cardiaca e sugl... 2023-05-25 due-trials